Brand semaglutide
Sold by Corsica Health · Injection, pen · every brand semaglutide record
What you actually pay
Per month
At least $1,499
| Medication · Ozempic, starting monthly price | $1,499 |
|---|---|
| Consultation fee · If you receive a medical consultation, medical consult fees are not subject to or eligible for a refund. | charged, amount not published |
A charge is disclosed without an amount, so this is a floor. We never count an unpriced charge as zero.
Price
| Term | Per month | Charged today |
|---|---|---|
| Ozempic, starting monthly price “Ozempic Experience Ozempic® (semaglutide) delivered through a once-weekly injectable treatment designed to support... Starting from $1,499.00 /mo” source, read September 2, 2026 | Per month$1,499 | Charged today$1,499 |
We earn nothing from this link. Corsica Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $1,499
- September 3, 2026 — $1,499
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | Not disclosed |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “Can I cancel anytime? Yes, subscriptions may be canceled at any time without penalties. We recommend discussing changes with your care team beforehand. Do you offer refunds? We offer a satisfaction guarantee for the first month. After shipment, products are generally non-refundable.” |
| Consult fee | Charged, and the amount is not published. If you receive a medical consultation, medical consult fees are not subject to or eligible for a refund. |
Not yet checked: pharmacy and membership.
Recorded from joincorsica.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The homepage advertises semaglutide 'Starting from $149.00/mo' and tirzepatide 'Starting from $249.00/mo,' which are the 3-month-plan monthly rates; the product pages also list separate, higher 1-month-plan prices ($249/mo semaglutide, $349/mo tirzepatide) — both are recorded as distinct entries rather than reconciled into one number. The semaglutide product page additionally showed a promo banner ('3-Month GLP-1 Supply for Just $250 with code USA250 → Only $83/month') that did not match the displayed $447 3-month price shown just below it on the same page — this discount-code price was not recorded as a confirmed entry since it may be an expired or conditional promotion, but is flagged here per the brief's instruction to note an advertised price that resolves to something else. Provider services are delivered through a named third party, TelegraMD, per the FAQ. State-availability text names an exclusion (SC, AL, AR) only for the sublingual/oral products, not the injectables reviewed here, so per the brief's rule against inverting an exclusion list into coverage, no state list was recorded.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.